BCL2 and lymphoma: Initially discovered in leukemia and lymphoma, antiapoptotic members of the Bcl-2 family, including Bcl-2, Bcl-xL, or Mcl-1, are frequently overexpressed in other neoplasia in order to block apoptosis in tumorigenesis.